FDA
- Status: approved
🇺🇸 Anti-CD20 antibodies in United States
2 US adverse-event reports
Marketing authorisation
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 20 April 2025 – 20 April 2026
- Total reports: 2
Most-reported reactions
- Gastric Cancer — 1 report (50%)
- Off Label Use — 1 report (50%)
Anti-CD20 antibodies in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Anti-CD20 antibodies approved in United States?
Yes. FDA has authorised it.
Who is the marketing authorisation holder for Anti-CD20 antibodies in United States?
Hansa Biopharma AB is the originator. The local marketing authorisation holder may differ — check the official source linked above.